Search

Your search keyword '"Light chain"' showing total 983 results

Search Constraints

Start Over You searched for: Descriptor "Light chain" Remove constraint Descriptor: "Light chain"
983 results on '"Light chain"'

Search Results

401. Morphologic Heterogeneity of Renal Light-Chain Deposition Disease.

402. A native antibody-based mobility-shift technique (NAMOS-assay) to determine the stoichiometry of multiprotein complexes

403. Bone marrow findings correlate with clinical outcome in systemic AL amyloidosis patients.

404. Gangliosides, Ab1 and Ab2 antibodies: II. Light versus heavy chain: An idiotype-anti-idiotype case study

405. Role of two active site Glu residues in the molecular action of botulinum neurotoxin endopeptidase

406. A novel subunit of axonemal dynein conserved among lower and higher eukaryotes

407. Treatment of Renal Failure Associated with Multiple Myeloma and Other Diseases by PACAP-38.

408. Urine from Scrapie-Infected Hamsters Comprises Low Levels of Prion Infectivity.

409. Expression, purification, and characterization of Clostridium botulinum type B light chain

410. PEGylated-nanoliposomal clusterin for amyloidogenic light chain-induced endothelial dysfunction

411. The pre-immune variable kappa repertoire of swine is selectively generated from certain subfamilies of Vκ2 and one Jκ gene

412. Differential Control of Clathrin Subunit Dynamics Measured with EW-FRAP Microscopy.

413. Specific degradation of H. pylori urease by a catalytic antibody light chain.

414. Immunology II: acquired immunity.

416. Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseases

417. Beta-2-glycoprotein specificity of human anti-phospholipid antibody resides on the light chain: a novel mechanism for acquisition of cross-reactivity by an autoantibody

418. Light chain muscle deposition caused rhabdomyolysis and acute renal failure in patient with multiple myeloma.

419. Analysis of strand biased ’G’·C hypermutation in human immunoglobulin Vλ gene segments suggests that both DNA strands are targets for deamination by activation-induced cytidine deaminase

420. Chemical characterization of a lambda I amyloid protein isolated from formalin- fixed and paraf fin-embedded tissue sections.

421. Cloning, high level expression, purification, and crystallization of the full length Clostridium botulinum neurotoxin type E light chain

422. Sperm motility-activating complex formed by <f>t</f>-complex distorters

423. Characterization of cDNA encoding immunoglobulin light chain of the mandarin fish (Siniperca chuatsi)

424. Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants

425. Analysis of B cell receptor production and rearrangement: Part I. Light chain rearrangement

426. Enzymatic Autocatalysis of Botulinum A Neurotoxin Light Chain.

427. Structure and diversity of Mexican axolotl lambda light chains.

428. Autoantibodies to Type VII Collagen Have Heterogeneous Subclass and Light Chain Compositions and Their Complement-Activating Capacities Do Not Correlate with the Inflammatory Clinical Phenotype.

429. Preparation and immunological features of syngeneic monoclonal anti-idiotypic antibody using complementary determining region (CDR) peptide as the immunogen.

430. Light Chain of Botulinum A Neurotoxin Expressed as an Inclusion Body from a Synthetic Gene Is Catalytically and Functionally Active.

431. Proteolytic components of serum IgG preparations.

432. Genomic Organization of the Serine Protease Light Chain of Mouse Complement Factor I Gene.

433. Natural catalytic immunity is not restricted to autoantigenic substrates.

434. Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma

435. Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons

436. First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience

437. Case Report: Systemic Amyloidosis Involving the Heart and Skeletal Muscle.

438. Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light Chains.

439. Light chain subunit of a poorly soluble human IgG2λ crystallizes in physiological pH environment both in cellulo and in vitro.

442. Peritumoral Immunoglobulin M Lambda Light Chain Amyloidosis in a Patient With Advanced Follicular Lymphoma.

443. Unraveling a rare cause of spinal stenosis: Coexistent AL and ATTR amyloidosis involving the ligamentum flavum.

444. Primary oral mucosa-associated lymphoid tissue (MALT) lymphoma in patient with monoclonale gammopathy: a rare case report.

445. Light Chain (AL) Cardiac Amyloidosis: A Diagnostic Dilemma.

448. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.

449. The Use of Somatic Hypermutation for the Affinity Maturation of Therapeutic Antibodies.

Catalog

Books, media, physical & digital resources